A recent study in patients with stable CAD demonstrated that low PCSK9 plasma levels are associated with low HDL-C, metabolic syndrome, obesity, insulin resistance, and diabetes, and diffuse non-obstructive coronary atherosclerosis [33]. Here, PCSK9 is linked to obesity due to melanocortin 4 receptor deficiency.